Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Index
-
Market Cap
39.18M
Enterprise Value
26.54M
Income
-16.04M
Sales
16.62M
Book/sh
2.15
Cash/sh
0.78
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
60
IPO
Jul 26, 2016
P/E
-
Forward P/E
-
PEG
-
P/S
2.36
P/B
1.11
P/C
3.03
P/FCF
-
EV/EBITDA
-
EV/Sales
1.60
Quick Ratio
3.25
Current Ratio
6.77
Debt/Eq
0.01
LT Debt/Eq
0.00
Option/Short
Yes / Yes
EPS (ttm)
-0.98
EPS next Y
-0.25
EPS next Q
-0.07
EPS this Y
-80.85%
EPS next Y
70.29%
EPS next 5Y
34.29%
EPS past 3/5Y
- -2.60%
Sales past 3/5Y
-14.86% 23.47%
EPS Y/Y TTM
-429.93%
Sales Y/Y TTM
-53.33%
EPS Q/Q
-56.92%
Sales Q/Q
-12.91%
Insider Own
18.67%
Insider Trans
10.22%
Inst Own
25.55%
Inst Trans
-3.08%
ROA
-32.44%
ROE
-37.02%
ROIC
-45.25%
Gross Margin
41.80%
Oper. Margin
-74.05%
Profit Margin
-96.49%
SMA20
-16.03%
SMA50
-18.23%
SMA200
-29.63%
Trades
Shs Outstand
16.46M
Shs Float
13.39M
52W High
5.49 -56.65%
52W Low
2.14 11.21%
Volatility
15.39% 14.46%
ATR (14)
0.34
RSI (14)
38.47
Beta
1.32
Rel Volume
0.83
Avg Volume
203.25K
Volume
133,570
Perf Week
-26.09%
Perf Month
-16.78%
Perf Quarter
-28.74%
Perf Half Y
-26.32%
Perf YTD
-40.20%
Perf Year
-41.09%
Perf 3Y
11.21%
Perf 5Y
-57.12%
Perf 10Y
-55.01%
Prev Close
2.30
Price
2.38
Change %
3.48%
Consensus
Strong Buy
Avg. Price Target
$5.25
Implied Upside
+120.6%
Analysts5incl. previous ratings
Rating Distribution4 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Mar 06, 2026Initiated
AAlliance Global Partners
Buy$7.50+215.1%
Jan 31, 2025Initiated
LLake Street
Buy$18+656.3%
Nov 15, 2024Reiterated
MMaxim Group
Buy$12 → $14+488.2%
Feb 26, 2021Upgrade
NNorthland Capital
Market Perform → Outperform
Dec 16, 2020Downgrade
NNorthland Capital
Outperform → Market Perform
Aug 10, 2020Upgrade
AAlliance Global Partners
Neutral → Buy$2.40 → $4.25+78.6%
Feb 14, 2020Upgrade
AAlliance Global Partners
Neutral → Buy$6+152.1%
Nov 07, 2019Downgrade
BB. Riley FBR
Buy → Neutral$14 → $5.50+131.1%
Jan 29, 2019Downgrade
NNorthland Capital
Market Perform → Under Perform
Sep 26, 2018Initiated
BB. Riley FBR
Buy$12.50+425.2%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cornish MeganDirectorNov 18 '26Buy2.282,2005,01634,200Nov 19 01:38 PM
Sachetta EricDirectorNov 17 '26Buy2.2481,575182,973376,359Nov 19 09:59 AM
Sardano Joseph CCHIEF EXECUTIVE OFFICERNov 16 '26Buy2.4030,00072,1081,250,293Nov 17 04:27 PM
Sachetta EricDirectorAug 28 '26Buy3.4437,537129,015267,480Aug 31 12:35 PM
Sachetta EricDirectorAug 31 '26Buy3.5427,30496,602294,784Aug 31 12:35 PM
Sachetta EricDirectorAug 27 '26Buy3.1810,92534,752229,943Aug 28 02:29 PM
Sachetta EricDirectorAug 26 '26Buy3.299,70831,930219,018Aug 28 02:29 PM
Sachetta EricDirectorAug 24 '26Buy3.2534,697112,904209,310Aug 25 09:26 AM
Sardano Joseph CCHIEF EXECUTIVE OFFICERAug 20 '26Buy3.0220,00060,4861,220,293Aug 24 04:00 PM
Sachetta EricDirectorAug 20 '26Buy3.1324,00075,072167,613Aug 24 03:08 PM
Sachetta EricDirectorAug 21 '26Buy3.257,00022,778174,613Aug 24 03:08 PM
Sachetta EricDirectorMay 12 '26Buy3.331,5005,002143,613May 12 01:53 PM
Sachetta EricDirectorFeb 24 '26Buy3.812,0007,620142,113Feb 26 09:25 AM
Sachetta EricDirectorNov 21 '25Buy3.937,00027,510140,113Nov 21 02:28 PM
Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.
Co-FounderMr. Joseph C. Sardano
PresidentMr. Michael J. Sardano J.D.
Chief Financial OfficerMr. Javier Rampolla
Chief Operating OfficerMs. Magdalena Martinez
Chief Technology OfficerMr. Carlton Chow